More Drugs to Fight High Cholesterol Are Emerging

The lipid-reducing medicines, among the most widely prescribed drugs in the U.S., have been a mainstay of heart-disease prevention and treatment for decades. Now some patients have other cholesterol-busting medicines available as options—and even more alternatives are on the horizon. Certain patients already can take a twice-yearly injection, sold by Novartis as Leqvio, that uses an RNA-based technology, or a more frequent injection that targets a protein called PCSK9 that interferes with the body’s ability to clear the bad form of cholesterol.

Continue Reading

View Comments